AVE 16.7% 0.3¢ avecho biotechnology limited

acquisitions, page-3

  1. 1,068 Posts.
    This stock is closely watched by a number of astute fund managers..... myself included

    BNB are in their and the stock has had two t/o attempts since listing.

    Assumming management continue doing what they are doing. there is no downside as the stock is already cheap.

    EBITDA and p/e ratios are low compared to other aged care operators around the world

    Additionally its a sector that private equity love - so realistically i dont think this stock will be listed in a few years.

    Buy as many as you can afford, put them in the bottom draw and wait, let time do its thing
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.